June 12, 2025
Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.
March 31, 2025
UNC Lineberger researchers have demonstrated a faster, more cost-effective approach to analyzing the genetic makeup of pediatric acute leukemia. Determining a cancer’s genomic classification is critical to developing a more effective treatment plan tailored to a patient’s tumor.
July 23, 2024
April 10, 2023
October 6, 2022
April 26, 2022
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.
September 13, 2021
September 10, 2021
Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.
December 8, 2020
Duane McKay and his daughter, Maddilyn, had cancer at the same time. Both were treated at the N.C. Cancer Hospital and received bone marrow transplants, with support from their small town community throughout their journey.
June 18, 2020
